Key result
This narrative review outlines existing knowledge and practical approaches for establishing and maintaining a multidisciplinary cardio-oncology program to manage cardiovascular adverse events in cancer patients.
Why the study?
New cancer treatments frequently cause serious cardiovascular adverse events, creating an urgent need for multidisciplinary teams to prevent, monitor, and treat cardiovascular disease in these patients.
This narrative review provides practical guidance on establishing and maintaining a multidisciplinary cardio-oncology clinic to manage cardiovascular adverse events associated with cancer treatments.
May aid clinic setup for cancer therapy cardiotoxicity; leaves open outcome validation in prospective studies.
The therapeutical advances in recent years in the field of oncology treatment have increased survival rates and improved the quality of life of oncology patients, thus turning cancer into a chronic disease. However, most of the new cancer treatments come at the expense of serious cardiovascular adverse events threatening the success story of these patients. The establishment of multidisciplinary medical teams to prevent, monitor, and treat cardiovascular diseases in cancer-treated patients is needed now more than ever. The aim of this narrative review is to demonstrate the existing knowledge and practical approaches on how to establish and maintain a cardio-oncology program for the rising number of patients who need it.
No takes yet. Share an insight, caveat, or question.
Chasouraki et al. (2022) conducted a review in Cardiovascular diseases in cancer-treated patients. Cardio-oncology program was evaluated. This narrative review outlines existing knowledge and practical approaches for establishing and maintaining a multidisciplinary cardio-oncology program to manage cardiovascular adverse events in cancer patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: